Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502644 · ClinicalTrials.gov registry record · Phase 4
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT01502644 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 81 participants.
The verdict
NCT01502644, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
Opioids are frequently prescribed for chronic low back pain (CLBP). Psychiatric illness, such as high levels of depression and anxiety symptoms, is a common co-occurrence in chronic pain patients (and is termed comorbid negative affect \[NA\]). The purpose of the study is to determine whether CLBP patients with either a high vs. a low or moderate degree of NA have different pain relief responses to oral opioids.
Interventions
- DRUG Placebo
- DRUG Oxycodone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01502644
The ClinicalTrials.gov registry entry for NCT01502644 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01502644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01502644 about?
NCT01502644 is a clinical study titled "Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms". Opioids are frequently prescribed for chronic low back pain (CLBP). Psychiatric illness, such as high levels of depression and anxiety symptoms, is a common co-occurrence in chronic pain patients (and is termed comorbid negative affect \[NA\]). The purpose of the study is to determine whether CLBP p...
What is the current status of trial NCT01502644?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2009-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01502644?
The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT01502644?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.